SCHEMBL5226041

SCHEMBL5226041

CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN)cc(N2CCCS2(=O)=O)c1

nearest known ligand 0.78

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.78
BACE2 Q9Y5Z0 19/20 0.78
CTSD P07339 17/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5217645 0.97 BACE1 (0.82) BACE1BACE2CTSD
SCHEMBL5226084 0.92 BACE1 (0.67) BACE1BACE2CTSD
SCHEMBL5226063 0.92 BACE1 (0.67) BACE1BACE2CTSD
SCHEMBL5220086 0.90 BACE1 (0.81) BACE1BACE2CTSD
SCHEMBL5217648 0.90 BACE1 (0.71) BACE1BACE2CTSD
SCHEMBL5217643 0.90 BACE1 (0.71) BACE1BACE2CTSD
SCHEMBL5221005 0.89 BACE1 (0.98) BACE1BACE2CTSD
SCHEMBL5222839 0.89 BACE1 (0.91) BACE1BACE2CTSD
SCHEMBL5223047 0.88 BACE1 (0.85) BACE1BACE2CTSD
Hydrochloric Acid SCHEMBL5217651 0.88 BACE1 (1.00) BACE1BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed